Celestica (NYSE:CLS) Shares Climb 1.7% - Still a Buy?

Key Points

• Celestica shares rose 1.7% to about $389.20, with trading volume roughly 51% below its average. The stock has a market capitalization of approximately $44.75 billion.
• Analysts remain broadly bullish: 23 rate CLS a Buy and one rates it Hold, producing a “Moderate Buy” consensus and an average price target of $450.50.
• Celestica recently exceeded quarterly expectations, reporting $2.54 in EPS versus $2.29 expected and $4.68 billion in revenue, up 62.4% year over year. However, insiders sold about $89.2 million of shares over the past 90 days.

Celestica, Inc. (NYSE:CLS - Get Free Report) TSE: CLS shares traded up 1.7% on Tuesday. The stock traded as high as $389.50 and last traded at $389.1950. Approximately 1,174,011 shares were traded during trading, a decline of 51% from the average session volume of 2,416,763 shares. The stock had previously closed at $382.69.

Wall Street Analyst Weigh In

CLS has been the topic of a number of analyst reports. TD Cowen restated a "buy" rating on shares of Celestica in a research report on Wednesday, September 16th. JPMorgan Chase & Co. raised their target price on Celestica from $445.00 to $485.00 and gave the stock an "overweight" rating in a research note on Wednesday, July 29th. Wolfe Research boosted their price target on Celestica from $425.00 to $475.00 and gave the company an "outperform" rating in a report on Wednesday, July 29th. TD set a $430.00 price objective on Celestica and gave the stock a "buy" rating in a report on Wednesday, September 16th. Finally, Scotiabank started coverage on Celestica in a research report on Tuesday, August 11th. They issued a "sector outperform" rating and a $500.00 price objective on the stock. Twenty-three analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $450.50.

Celestica Price Performance

The stock has a market cap of $44.75 billion, a P/E ratio of 40.46 and a beta of 2.01. The firm has a 50-day moving average price of $331.68 and a 200-day moving average price of $346.70. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.68 and a current ratio of 1.23.

Celestica (NYSE:CLS - Get Free Report) TSE: CLS last released its quarterly earnings results on Monday, July 27th. The technology company reported $2.54 earnings per share for the quarter, beating the consensus estimate of $2.29 by $0.25. The company had revenue of $4.68 billion for the quarter, compared to analyst estimates of $4.30 billion. Celestica had a return on equity of 39.96% and a net margin of 7.16%.The firm's revenue was up 62.4% on a year-over-year basis. During the same period in the previous year, the company posted $1.39 earnings per share. Celestica has set its FY 2026 guidance at 11.300-11.300 EPS and its Q3 2026 guidance at 2.880-3.080 EPS. On average, analysts forecast that Celestica, Inc. will post 10.71 earnings per share for the current fiscal year.

Insider Activity

In other news, CEO Robert Mionis sold 23,396 shares of the company's stock in a transaction dated Wednesday, September 23rd. The shares were sold at an average price of $364.22, for a total value of $8,521,291.12. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, President Todd Cooper sold 20,118 shares of the stock in a transaction dated Wednesday, September 23rd. The stock was sold at an average price of $360.00, for a total transaction of $7,242,480.00. Following the completion of the transaction, the president owned 73,252 shares of the company's stock, valued at approximately $26,370,720. The trade was a 21.55% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 243,067 shares of company stock worth $89,200,967. Corporate insiders own 1.10% of the company's stock.

Hedge Funds Weigh In On Celestica

A number of institutional investors and hedge funds have recently made changes to their positions in CLS. JPMorgan Chase & Co. boosted its position in shares of Celestica by 24.8% in the 4th quarter. JPMorgan Chase & Co. now owns 4,017,623 shares of the technology company's stock worth $1,187,650,000 after purchasing an additional 798,782 shares in the last quarter. Franklin Resources Inc. increased its position in Celestica by 18.6% during the 4th quarter. Franklin Resources Inc. now owns 2,278,214 shares of the technology company's stock valued at $673,471,000 after buying an additional 356,797 shares in the last quarter. Cibc World Market Inc. bought a new stake in Celestica in the second quarter worth $757,811,000. Connor Clark & Lunn Investment Management Ltd. purchased a new stake in shares of Celestica in the second quarter worth $674,199,000. Finally, Royal Bank of Canada grew its stake in shares of Celestica by 13.8% in the first quarter. Royal Bank of Canada now owns 1,283,561 shares of the technology company's stock worth $361,553,000 after acquiring an additional 156,040 shares during the last quarter. Institutional investors own 67.38% of the company's stock.

Celestica Company Profile

Celestica Inc NYSE: CLS is a global provider of design, manufacturing, and supply-chain services for original equipment manufacturers and other technology companies. The company helps customers develop, produce, deploy, and support complex hardware and electronic systems, serving industries such as communications, enterprise technology, aerospace and defense, industrial technology, health care, and semiconductor equipment.

Its services include product design and engineering, printed circuit board and systems assembly, manufacturing, testing, logistics, aftermarket support, and supply-chain management.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.